Non-Seminomatous Germ Cell Tumor — Trials

Non-Seminomatous Germ Cell Tumor — Trials · CancerIndex

Clinical trials

Registered studies

15 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 6
Recruiting: 3
Ph III recruiting: 1
Growth YoY: —
Industry share: 0%
Top sponsor: Alliance for Clinical Trials in Oncology
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1)

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02499952	Pembrolizumab in Subjects With Incurable Platinum-Refractory Germ Cell Tumors	terminated	Phase 2	12	Nasser Hanna, M.D.OTHER	1	Jul 11, 2022	clinicaltrials

Data updated 22 days agoSource updated Jul 11, 2022source: clinicaltrials